868 - In Vitro Activity of Isavuconazole and Other Mould-Active Triazoles Against Aspergillus fumigatus With and Without cyp51 Alterations

Friday, October 21, 2022

10:30 AM – 10:45 AM US ET

Location: 147 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Co-Author(s)

MP

Michael A. Pfaller, MD

Consultant Director
JMI Laboratories
North Liberty, Iowa, United States

Disclosure: Disclosure(s): Pfizer: Grant/Research Support ()

Presenting Author(s)

Cecilia G. Carvalhaes, MD, PhD

Associate Director for Clinical Microbiology
JMI Laboratories
North Liberty, Iowa, United States

Disclosure: Disclosure(s): AbbVie: Grant/Research Support (); Cidara: Grant/Research Support (); Melinta: Grant/Research Support (); Pfizer: Grant/Research Support ()

Co-Author(s)

LD

Lalitagauri M. Deshpande, PhD

Research Scientist
JMI Laboratories
North Liberty, Iowa, United States

Disclosure: Disclosure(s): Melinta: Grant/Research Support (); Pfizer: Grant/Research Support ()
PR

Paul Rhomberg, BS, MT(ASCP)

Drug Development Manager
JMI Laboratories
North Liberty, Iowa, United States

Disclosure: Disclosure(s): Cidara: Grant/Research Support (); Pfizer: Grant/Research Support ()
Mariana Castanheira, PhD

Chief Scientific Officer
JMI Laboratories
North Liberty, Iowa, United States

Disclosure: Disclosure(s): No financial relationships to disclose

Disclosure(s):

Michael A. Pfaller, MD: Pfizer: Grant/Research Support ()

Cecilia G. Carvalhaes, MD, PhD: AbbVie: Grant/Research Support (); Cidara: Grant/Research Support (); Melinta: Grant/Research Support (); Pfizer: Grant/Research Support ()

Lalitagauri M. Deshpande, PhD: Melinta: Grant/Research Support (); Pfizer: Grant/Research Support ()

Paul Rhomberg, BS, MT(ASCP): Cidara: Grant/Research Support (); Pfizer: Grant/Research Support ()

Mariana Castanheira, PhD: No financial relationships to disclose